{
    "clinical_study": {
        "@rank": "20007", 
        "acronym": "iTransmit", 
        "brief_summary": {
            "textblock": "The investigators goal in this study is to examine the feasibility and efficacy of AliveCor\n      iphone case monitoring device in monitoring patients after AF ablation by comparing\n      transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor\n      (TTM).\n\n      A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM\n      system from the patient's perspective"
        }, 
        "brief_title": "Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Persistent Atrial Fibrillation", 
            "Paroxysmal Atrial Fibrillation"
        ], 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female between > 18 and < 75 years of age\n\n          2. Paroxysmal or persistent atrial fibrillation\n\n          3. Scheduled to undergo an AF ablation procedure\n\n          4. Already has iPhone 4 or iPhone 4S with data plan\n\n          5. Willing to use the iPhone Alive Cor case\n\n          6. Written informed consent\n\n        Exclusion Criteria:\n\n          1. Unable or unwilling to use the Alive Cor case for their iPhone or iPhone 4S\n\n          2. Residing outside the United States"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing A-fib ablations."
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01912911", 
            "org_study_id": "13-521"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 29, 2013", 
        "location": {
            "contact": {
                "last_name": "Khaldoun Tarakji, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44195"
                }, 
                "name": "Cleveland Clinic HVI"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "The Cleveland Clinic", 
            "last_name": "Khaldoun Tarajki, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The proportion of AF/flutter events detected by the AliveCor device will be compared to events detected by the TTM for each episode.", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01912911"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Cleveland Clinic", 
            "investigator_full_name": "Khaldoun Tarakji", 
            "investigator_title": "MD MPH", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Amount of transmissions from smartphone in comparison with traditional TTM method", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "The Cleveland Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Cleveland Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}